The impact of trisomy 21 on epidemiology, management, and outcomes of congenital duodenal obstruction: a population-based study
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Feb 2020 · 1 min read
In brief
In brief
This UK population-based study of 102 infants with congenital duodenal obstruction found that trisomy 21 was present in 32% of cases and associated with higher rates of cardiac anomalies and longer hospital stays, but did not affect surgical management or mortality outcomes.
Written by the GCMD Library team from the article.
Abstract
Purpose
Congenital duodenal obstruction (CDO) is associated with trisomy 21 (T21), or Down’s syndrome, in around a third of infants. The aim of this study was to explore the impact of T21 on the epidemiology, management, and outcomes of infants with CDO.
Methods
Data were prospectively collected from specialist neonatal surgical centres in the United Kingdom over a 12 month period from March 2016 using established population-based methodology for all babies with CDO. Infants with T21 were compared to those without any chromosomal anomaly.
Results
Of 102 infants with CDO that underwent operative repair, T21 was present in 33 [32% (95% CI 23–41%)] babies. Cardiac anomalies were more common in those with T21 compared to those without a chromosomal anomaly (91 vs 17%, p < 0.001), whereas associated gastrointestinal anomalies were less common in infants with T21 (3 vs 12%, p = 0.03). Surgical management was not influenced by T21. Time to achieve full enteral feed, need for repeat related surgery, and mortality were similar between groups. Infants with T21 had a longer median initial inpatient stay (23 vs 16.5 days, p = 0.02).
Conclusions
Infants with T21 have a higher incidence of cardiac anomalies and a longer initial inpatient stay; however, it does not change CDO management or outcomes. This information is important for prenatal and postnatal counselling of parents of infants with CDO and T21.